Skip to content
Research Article Open access CC BY 4.0

Newly Emerging Candida Specie: Should Clinicians and Mycologist be Concerned?

O. F. Ashcroft, A. S. Kumurya, K. Mohammed, M. U. Iduh, A. A. Yusuf, N. M. Bunza, S. U. Nataala

Asian Journal of Research in Infectious Diseases · pp. 1–7 · Published 9 Aug 2019

10.9734/ajrid/2019/v2i430109

Abstract

The emergence of C. auris as a global nosocomial pathogen associated with multidrug resistance and high mortality rates has been recently discovered. This emerging pathogen appears to be far more able to induce systemic infection and mortality than other potential multi drug resistance (MDR) yeast pathogens even though it is found to have reduced virulence factors compared to C. albicans. There are issues with regard to the identification of C. auris using both phenotypic and molecular techniques; this has raised concerns about detecting the true scale of the problem. This mini- review elucidates on the literature available on C. auris and highlights the mechanism of pathogenesis and antifungal resistance, which will give further direction to extensive research in this field.

Candida auris emerging infection nosocomial pathogens antifungal susceptibility pathogenesis.

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.